Pressrelease – Lund, June 23rd, 2026 – Hamlet BioPharma’s monthly digital investors’ meeting on June 30th

Hamlet Biopharma
|
June 23, 2026

Hamlet BioPharma invites you to our monthly investors’ meeting to be held on the 30th of June 2026, at 12:00.

Please click on the link below to participate in the meeting

https://us06web.zoom.us/j/83747321138?pwd=PIw6kh3f0CY20DAbrtYx3fbzQMCBco.1

For further information please contact:

Jakob Testad, CFO, Hamlet BioPharma AB, +46 708 48 42 10, jakob.testad@hamletbiopharma.com
Catharina Svanborg, Chair of the Board, Hamlet BioPharma, +46-709 42 65 49, catharina.svanborg@hamletpharma.com

www.hamletbiopharma.com

An innovative pharmaceutical company with a broad and strong portfolio of projects for the treatment of cancer and infections.
Hamlet BioPharma AB
Klinikgatan 32
SE-222 42 Lund
info@hamletbiopharma.com
Org. no. 556568-8958
Subscribe to receive
Pressreleases and Newsletters
© 2026
Hamlet BioPharma.